"Coronary Restenosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Recurrent narrowing or constriction of a coronary artery following surgical procedures performed to alleviate a prior obstruction.
Descriptor ID |
D023903
|
MeSH Number(s) |
C14.280.647.250.285.200 C14.907.585.250.285.200
|
Concept/Terms |
Coronary Restenosis- Coronary Restenosis
- Coronary Restenoses
- Restenoses, Coronary
- Restenosis, Coronary
|
Below are MeSH descriptors whose meaning is more general than "Coronary Restenosis".
Below are MeSH descriptors whose meaning is more specific than "Coronary Restenosis".
This graph shows the total number of publications written about "Coronary Restenosis" by people in this website by year, and whether "Coronary Restenosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2009 | 2 | 0 | 2 |
2010 | 0 | 1 | 1 |
2011 | 0 | 1 | 1 |
2013 | 1 | 1 | 2 |
2015 | 1 | 0 | 1 |
2016 | 2 | 0 | 2 |
2018 | 1 | 0 | 1 |
2020 | 1 | 1 | 2 |
2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Coronary Restenosis" by people in Profiles.
-
Prognostic impact of in-stent restenosis in normal weight, overweight, and obese patients undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv. 2024 Feb; 103(2):260-267.
-
Procedural and 1-year clinical outcomes of orbital atherectomy for treatment of coronary in-stent restenosis: A single-center, retrospective study. Catheter Cardiovasc Interv. 2021 02 15; 97(3):E280-E287.
-
Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk: A Patient-Level Stratified Analysis From Four Postapproval Studies. Circulation. 2020 03 17; 141(11):891-901.
-
Intravascular Brachytherapy for the Management of Repeated Multimetal-Layered Drug-Eluting Coronary Stent Restenosis. Circ Cardiovasc Interv. 2018 10; 11(10):e006832.
-
Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: Rationale and design of the TWILIGHT study. Am Heart J. 2016 Dec; 182:125-134.
-
Resistant in-stent restenosis in the drug eluting stent era. Catheter Cardiovasc Interv. 2016 Nov; 88(5):777-785.
-
Endobronchial biopsies on aspirin and prasugrel. Heart Lung Circ. 2015 Jun; 24(6):e68-70.
-
Safety and efficacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trials. Lancet. 2013 Dec 07; 382(9908):1879-88.
-
Systematic review of effectiveness of oral sirolimus after bare-metal stenting of coronary arteries for prevention of in-stent restenosis. Am J Cardiol. 2013 Nov 01; 112(9):1322-7.
-
Drug eluting versus bare metal stents in cardiac allograft vasculopathy: a systematic review of literature. Catheter Cardiovasc Interv. 2011 Jun 01; 77(7):962-9.